Omega Century Institute Of Oncology Private Limited, a active private limited company, was established on 25 October 2018 in Hyderabad, Telangana, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U85100TG2018PTC127868. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Its leadership includes Hara Govind Chigurupati (Director), Mohan Vamsy Chigurupati (Director). Past directors included Hara Govind Chigurupati, Namrata Chigurupati, Sridhar Peddireddy. It holds no open charges and ₹4.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.269,Road No.14,Nandinagar Banjara Hills, Hyderabad, Telangana, 500034.
U85100TG2018PTC127868
127868
25 October 2018
₹1.00 Cr
₹1.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Omega Century Institute Of Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hara Govind Chigurupati | Director | 16 Aug 2022 | Current |
| Mohan Vamsy Chigurupati | Director | 25 Oct 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
| Pramod Abcsdd | Director | 04 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Omega Century Institute Of Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.02% increase. The company also saw a substantial improvement in profitability, with a 82.66% increase in profit. The company's net worth dipped by a decrease of 8.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Omega Century Institute Of Oncology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹46,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jun 2020 | Others | ₹4.05 Cr | Satisfied |
| 09 May 2019 | Others | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Omega Century Institute Of Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Omega Century Institute Of Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omega Century Institute Of Oncology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Omega Century Institute Of Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Omega Century Institute Of Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge registered on 15 Jun 2020 via Charge ID 100346398 with Others was fully satisfied on 02 May 2023. was recorded as a recent event.
A charge registered on 09 May 2019 via Charge ID 100264545 with Others was fully satisfied on 02 May 2023. was recorded as a recent event.
Progress on Hara Govind Chigurupati was appointed as a Director was appointed as a Director on 16 Aug 2022 & has been associated with this company since 3 years 3 months . was documented.
Progress on A charge with Others amounted to Rs. 4.05 Cr with Charge ID 100346398 was registered on 15 Jun 2020. was documented.
The CIN of Omega Century Institute Of Oncology Private Limited is U85100TG2018PTC127868.
Omega Century Institute Of Oncology Private Limited is headquartered at Plot No.269,Road No.14,Nandinagar Banjara Hills, Hyderabad, Telangana, 500034.
Omega Century Institute Of Oncology Private Limited was incorporated on 25 October 2018.
The current directors of Omega Century Institute Of Oncology Private Limited are
The primary industry of Omega Century Institute Of Oncology Private Limited is Hospital And Medical Care.
Omega Century Institute Of Oncology Private Limited is unlisted.
The authorized capital of Omega Century Institute Of Oncology Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX